9 insiders reported 48 Form 4 transactions for Olema Pharmaceuticals, Inc. (OLMA) over the past 18 months (most recent 2026-07-27). Recent activity: Harmon Cyrus (Director) Sell 12,500 shares, Harmon Cyrus (Director) Sell 12,500 shares, Mitchell Shawnte (CHIEF LEGAL OFFICER) Buy 15,000 shares, Mitchell Shawnte (CHIEF LEGAL OFFICER) Sell 15,000 shares, Mitchell Shawnte (CHIEF LEGAL OFFICER) Buy 25,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Harmon Cyrus | Director | Sell | 12,500 | $144,738 |
| 2026-07-27 | Harmon Cyrus | Director | Sell | 12,500 | $146,425 |
| 2026-03-05 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Buy | 15,000 | $65,550 |
| 2026-03-05 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell | 15,000 | $345,150 |
| 2026-03-05 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Buy | 25,000 | $109,250 |
| 2026-03-05 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell | 24,767 | $600,600 |
| 2026-03-05 | Mitchell Shawnte | CHIEF LEGAL OFFICER | Sell | 233 | $5,753 |
| 2026-02-17 | Austin Sasha Lu | VP of Finance and Controller | Buy | 11,700 | $0 |
| 2026-01-21 | Harmon Cyrus | Director | Sell | 10,000 | $268,800 |
| 2026-01-16 | Harmon Cyrus | Director | Sell | 3,489 | $101,600 |
| 2026-01-15 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sell | 3,822 | $107,054 |
| 2026-01-15 | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sell | 100,000 | $2.9M |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 10,000 | $283,400 |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $243,500 |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 49,800 | $1.4M |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 200 | $5,698 |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $243,500 |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 14,997 | $428,914 |
| 2026-01-14 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 35,003 | $1.0M |
| 2025-12-30 | Bohen Sean | President and CEO | Sell | 8,500 | $0 |
| 2025-12-29 | Harmon Cyrus | Director | Sell | 2,881 | $82,195 |
| 2025-12-23 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 1,225 | $34,398 |
| 2025-12-23 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 43,729 | $1.3M |
| 2025-12-23 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 6,046 | $189,784 |
| 2025-12-23 | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sell | 9,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-27